Cathie Wood Is Selling These 5 Stocks
Cathie Wood’s hedge fund bought a new stake in Cloud data services company Netapp in the fourth quarter of 2021.
Redhill Biopharma Ltd. (RDHL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,822 | $38,674 | 0.01% | |
| 2. | 3,388 | $7,352 | 0% | |
| 3. | 1,768 | $3,834 | 0% | |
| 4. | 303 | $658 | 0% | |
| 5. | 135 | $293 | 0% |
News See All
Cathie Wood's Latest Portfolio: 5 Stocks Under $10
In this article, we discuss 5 stocks under $10 in Cathie Wood's latest portfolio.
Cathie Wood's Latest Portfolio: 10 New Stock Picks in 2022
Despite huge criticism and losses, Cathie Wood’s hedge fund ARK Investment continues to attract investors amid promises of future growth.
5 Biotech Stocks to Sell Now According to Cathie Wood
In this article, we discuss 5 biotech stocks to sell now according to Cathie Wood.
11 Best Covid Vaccine and Pill Stocks To Invest In
In this article, we discuss the 11 best Covid vaccine and pill stocks to invest in.
Is RDHL Stock A Buy Here?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
Do Hedge Funds Love RedHill Biopharma Ltd (RDHL)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Avoided Losses in RedHill Biopharma Ltd (RDHL)
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
Here’s Our RedHill Biopharma Ltd – ADR (RDHL) Yeliva Phase II Preview
RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) just announced the initiation of the latest element of its Yeliva development program, and the company has teed up for a number of near term catalysts on the...
RedHill Biopharma Ltd – ADR (RDHL) GI Topline Is Set For 2016 Release
RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) just informed markets that it intends to put out topline data from its phase III trial of Bekinda in a gastroenteritis indication.